Publicacións en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (22)

2023

  1. European Association of Urology biochemical recurrence risk groups after radical prostatectomy: external validation and identification of independent risk factors for progression and death

    Actas Urologicas Espanolas, Vol. 47, Núm. 7, pp. 422-429

2022

  1. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E

    Bladder Cancer, Vol. 8, Núm. 4, pp. 379-393

  2. Current trends in erectile rehabilitation after radical prostatectomy: Results from a worldwide survey

    Andrologia, Vol. 54, Núm. 9

2021

  1. Comparative assessment of biodegradable-antireflux heparine coated ureteral stent: animal model study

    BMC Urology, Vol. 21, Núm. 1

  2. Long-term experience with hyperthermic chemotherapy (Hivec) using mitomycin-c in patients with non-muscle invasive bladder cancer in Spain

    Journal of Clinical Medicine, Vol. 10, Núm. 21

2020

  1. A global knowledge, attitudes and practices survey on anatomical endoscopic enucleation of prostate for benign prostatic hyperplasia among urologists

    Andrologia, Vol. 52, Núm. 8

  2. Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 156-163

  3. Andrología y cáncer de pene. Recomendaciones durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 395-404

  4. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis

    Neurourology and Urodynamics, Vol. 39, Núm. 2, pp. 762-770

  5. Social media influence in the COVID-19 pandemic

    International Braz J Urol, Vol. 46, pp. 120-124

2019

  1. Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group)

    Actas Urologicas Espanolas, Vol. 43, Núm. 1, pp. 4-11

2018

  1. Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity

    Actas Urologicas Espanolas

  2. Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice

    Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248

2017

  1. Consenso sobre el manejo del cáncer de próstata resistente a la castración avanzado en España

    Archivos Espanoles de Urologia, Vol. 70, Núm. 9, pp. 777-791

  2. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group

    Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367

2016

  1. Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP

    Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216

2014

  1. Bone health in patients with prostate cancer

    Actas urologicas espanolas

  2. Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options

    Actas Urologicas Espanolas

  3. Terapia focal en cáncer de próstata. Alternativas de tratamiento

    Actas Urologicas Espanolas

2013

  1. Registro nacional de cáncer de próstata 2010 en España

    Actas Urologicas Espanolas, Vol. 37, Núm. 1, pp. 12-19